Key Takeaways

• Rem3dy Health secures £14 million to boost global expansion and AI-driven nutrition.
• The company, valued at £84 million, will enter international markets including the US and India.
• Investment highlights a shift towards innovative health tech, with strong backing from major global investors.

Funding Boost for Global Expansion

Midlands-based Rem3dy Health has raised £14 million to accelerate its growth in the personalized nutrition market. This funding round, which values the company at £84 million, was spearheaded by notable global investors such as Suntory, Estrella Galicia, Apollo Hospitals, and UPSA. Additionally, Birmingham’s Future Planet Capital Regional reinforced the firm’s roots within the UK innovation scene.

The investment is earmarked for expanding into international regions such as the United States, MENA, and India, alongside enhancing automation and AI-driven personalized nutrition solutions. Considering the increasing consumer interest in tailored wellness, Rem3dy also plans to broaden its product offerings to include personalized health solutions for pets.

Founded in Birmingham, Rem3dy Health is leveraging AI, data science, and 3D printing to provide personalized health solutions efficiently. The company boasts a robust portfolio of 29 patents and emphasizes sustainable packaging and production methods. This positions Rem3dy at the nexus of health, technology, and sustainability.

The funding follows a transformative year for Rem3dy Health, which recorded revenue of £10.21 million—61% growth from 2024. Production yields improved, rising from 91% to 97%, while efficiency increased from 86% to 95%. Currently, the company produces about 500,000 personalized gummies daily and has manufactured over 150 million personalized nutrient stacks since adopting its new production technology.

Key partnerships have expanded with major UK retailers such as Boots, Holland & Barrett, and Ocado, while reaching into additional European markets. This investment signifies a strategic shift in the healthcare landscape, as established companies increasingly support next-gen health tech enterprises. For instance, Estrella Galicia’s involvement reflects its interest in diversifying into new areas, while Apollo Hospitals provides invaluable insight from one of the largest integrated healthcare organizations globally.

Rem3dy Health has also benefited from initiatives by the UK Department for Business & Trade (DBT). Founder Melissa Snover was selected for the inaugural DBT Female Founders Initiative—supporting promising female-led tech companies through mentorship and investor connections.

This recognition is notable amid a challenging funding environment for female entrepreneurs in the UK, where female-founded teams currently receive only about 2% of total venture capital. Snover expressed that securing this funding marks a significant milestone for the company, enabling it to scale globally while focusing on automation and AI personalisation.

José Cabanas, CMO at Hijos de Rivera, highlighted the merger of expertise and technology within Rem3dy, which positions the company at the forefront of innovative nutritional solutions. With this funding, Rem3dy is set to build on its proven domestic success to expand its international footprint and develop new products in collaboration with strategic partners.

The content above is a summary. For more details, see the source article.